« Back to Directory of Resources
Treatments Under Development
Here you will find a list of current treatments under development:
| Brand Name: | Treanda |
| Generic Name: | bendamustine |
| Code Name: | SDX-105 |
| Company: | Cephalon Oncology |
| FDA Clinical Phase: | 1/2 |
Description:
Treanda (news articles) is a drug that is …
| Brand Name: | Zolinza |
| Generic Name: | vorinostat |
| Code Name: | MK0683 |
| Company: | Merck Pharmaceuticals |
| FDA Clinical Phase: | 1, 2, & 3 |
Description:
Zolinza (news articles), which is …
| Brand Name: | |
| Generic Name: | pomalidomide |
| Code Name: | CC-4047, Actimid |
| Company: | Celgene |
| FDA Clinical Phase: | 1/2 |
Description:
Pomalidomide (new articles, forum discussions) is an immunomodulatory agent (a drug that affects the immune system) that encourages a patient’s immune system to attack and destroy myeloma cells.| Brand Name: | |
| Generic Name: | |
| Code Name: | MAGE-A3 and NY-ESO-1 |
| Company: | University of Arkansas |
| FDA Clinical Phase: | 2/3 |
Description:
The purpose of MAGE-A3 and NY-ESO-1 immunotherapy is to generate anti-myeloma T-cells (natural immune system cells) to kill myeloma cells and nothing else.| Brand Name: | |
| Generic Name: | ridaforolimus (formerly deforolimus) |
| Code Name: | AP23573 |
| Company: | Ariad Pharmaceuticals & Merck |
| FDA Clinical Phase: | 1 |
Description:
Ridaforolimus, formerly known as deforolimus, is …
| Brand Name: | |
| Generic Name: | |
| Code Name: | CX-4945 |
| Company: | Cylene |
| FDA Clinical Phase: | 1 |
Description:
CX-4945 is an oral anti-cancer agent. It inhibits CK2, an enzyme …
